heart failure semaglutide VisualAbstract: Improves Outcomes in Patients with Obesity-Related and Type 2 Diabetes Effects of Semaglutide on Heart

Effects of Tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data

Its generally less powerful than tirzepatide or high-dose semaglutide

October 2025 : The Wegovy warning label was updated to include Severe Gastrointestinal Adverse Reactions in the WARNINGS AND PRECAUTIONS section

The STEP trials, which tested semaglutide for weight loss in over 5,000 patients, documented baseline and follow-up blood pressure measurements

Meeting even basic protein needs can be hard on a drug that blunts appetite this much

Answer: Retatrutide is not FDA approved as of April 2026 and not EMA approved either